Limits...
ST-Elevation Myocardial Infarction After Sumitriptan Ingestion in Patient with Normal Coronary Arteries.

Jensen C, Riddle M - West J Emerg Med (2015)

Bottom Line: Sumitriptan has been used by millions as a migraine abortant; however, there have been studies showing angina pectoris, coronary vasospasm, and even myocardial infarction in patients with predisposing cardiac risk factors.The majority are patients using the injectable form subcutaneously.We present the case of a patient who presents with ST-elevation myocardial infarction, with no cardiovascular risk factors, after ingesting oral sumitriptan for her typical migraine.

View Article: PubMed Central - PubMed

Affiliation: Carl R. Darnall Army Medical Center, Department of Emergency Medicine, Fort Hood, Texas.

ABSTRACT
Sumitriptan has been used by millions as a migraine abortant; however, there have been studies showing angina pectoris, coronary vasospasm, and even myocardial infarction in patients with predisposing cardiac risk factors. The majority are patients using the injectable form subcutaneously. We present the case of a patient who presents with ST-elevation myocardial infarction, with no cardiovascular risk factors, after ingesting oral sumitriptan for her typical migraine.

No MeSH data available.


Related in: MedlinePlus

Post-nitroglycerine electrocardiogram with resolution of ST-elevation myocardial infarction.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4644054&req=5

f3-wjem-16-781: Post-nitroglycerine electrocardiogram with resolution of ST-elevation myocardial infarction.

Mentions: During patient transport, her pain gradually improved after administration of the nitroglycerine and a second ECG was electronically transmitted (Figure 2) which showed some improvement in the ischemic changes. Once she arrived to the ED, her chest pain had nearly resolved, she had stable vitals and her arrival ED ECG showed resolution of ischemic changes (Figure 3). Cardiac enzymes showed an initial troponin of 0.05ng/mL. Urine drug screen was negative, confirming that no recreational drug use, to include cocaine, was used. Cardiology was present in the ED and elected to take the patient for emergent coronary angiography.


ST-Elevation Myocardial Infarction After Sumitriptan Ingestion in Patient with Normal Coronary Arteries.

Jensen C, Riddle M - West J Emerg Med (2015)

Post-nitroglycerine electrocardiogram with resolution of ST-elevation myocardial infarction.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4644054&req=5

f3-wjem-16-781: Post-nitroglycerine electrocardiogram with resolution of ST-elevation myocardial infarction.
Mentions: During patient transport, her pain gradually improved after administration of the nitroglycerine and a second ECG was electronically transmitted (Figure 2) which showed some improvement in the ischemic changes. Once she arrived to the ED, her chest pain had nearly resolved, she had stable vitals and her arrival ED ECG showed resolution of ischemic changes (Figure 3). Cardiac enzymes showed an initial troponin of 0.05ng/mL. Urine drug screen was negative, confirming that no recreational drug use, to include cocaine, was used. Cardiology was present in the ED and elected to take the patient for emergent coronary angiography.

Bottom Line: Sumitriptan has been used by millions as a migraine abortant; however, there have been studies showing angina pectoris, coronary vasospasm, and even myocardial infarction in patients with predisposing cardiac risk factors.The majority are patients using the injectable form subcutaneously.We present the case of a patient who presents with ST-elevation myocardial infarction, with no cardiovascular risk factors, after ingesting oral sumitriptan for her typical migraine.

View Article: PubMed Central - PubMed

Affiliation: Carl R. Darnall Army Medical Center, Department of Emergency Medicine, Fort Hood, Texas.

ABSTRACT
Sumitriptan has been used by millions as a migraine abortant; however, there have been studies showing angina pectoris, coronary vasospasm, and even myocardial infarction in patients with predisposing cardiac risk factors. The majority are patients using the injectable form subcutaneously. We present the case of a patient who presents with ST-elevation myocardial infarction, with no cardiovascular risk factors, after ingesting oral sumitriptan for her typical migraine.

No MeSH data available.


Related in: MedlinePlus